doxorubicin hydrochloride has been researched along with parthenolide, (1ar-(1ar*,4e,7as*,10as*,10br*))-isomer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Chen, Y; Ding, Y; Ge, W; Li, S; Liu, Z; Wang, M; Zhang, Q; Zhang, X | 1 |
1 other study(ies) available for doxorubicin hydrochloride and parthenolide, (1ar-(1ar*,4e,7as*,10as*,10br*))-isomer
| Article | Year |
|---|---|
Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Nucleus; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Liver Neoplasms; Molecular Structure; Sesquiterpenes; Structure-Activity Relationship; Tumor Cells, Cultured | 2019 |